Trial intelligence / Profile preview

Analgesic efficacy of repetitive nerve blockade after major ankle and hindfoot surgery

2020-000294-24Phase 4Terminated

Sponsor
Aarhus University Hospital
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of bupivacaine in postoperative pain, sponsored by Aarhus University Hospital. Primary endpoint: Cumulated opioid usage 48 h postoperatively. Started Jun 2020; status: terminated.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2020-000294-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-000294-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call